Osteoporosis Management Strategies in the COVID-19 Pandemic.
作者信息
Sundaresh Vishnu
机构信息
From the Division of Endocrinology, Metabolism and Diabetes, University of Utah School of Medicine, Salt Lake City.
出版信息
South Med J. 2020 Dec;113(12):612-613. doi: 10.14423/SMJ.0000000000001179.
Abstract
摘要
相似文献
1
Osteoporosis Management Strategies in the COVID-19 Pandemic.新冠疫情期间的骨质疏松症管理策略
South Med J. 2020 Dec;113(12):612-613. doi: 10.14423/SMJ.0000000000001179.
2
Osteoporosis Management in the Era of COVID-19.COVID-19 时代的骨质疏松症管理。
J Bone Miner Res. 2020 Jun;35(6):1009-1013. doi: 10.1002/jbmr.4049. Epub 2020 May 26.
3
Osteoporosis Management.骨质疏松症管理
J Womens Health (Larchmt). 2017 Aug;26(8):918-921. doi: 10.1089/jwh.2017.6496. Epub 2017 Jul 7.
4
[Should we treat thalassemia-induced osteoporosis: two case reports].[我们应该治疗地中海贫血所致骨质疏松症吗：两例报告]
Praxis (Bern 1994). 2012 Oct 3;101(20):1325-9. doi: 10.1024/1661-8157/a001076.
5
Clinical practice. Osteoporosis in men.临床实践。男性骨质疏松症
N Engl J Med. 2008 Apr 3;358(14):1474-82. doi: 10.1056/NEJMcp0707217.
6
Innovative interventions. What's new and what's ahead for osteoporosis.创新干预措施。骨质疏松症的新进展与未来展望。
Adv Nurse Pract. 2006 Sep;14(9):43-6, 56.
7
Osteoporosis management in Australian general practice: an analysis of current osteoporosis treatment patterns and gaps in practice.澳大利亚全科医学中的骨质疏松症管理：当前骨质疏松症治疗模式的分析及实践中的差距。
BMC Fam Pract. 2020 Feb 12;21(1):32. doi: 10.1186/s12875-020-01103-2.
8
[Management of osteoporosis after fragility fractures].[脆性骨折后骨质疏松症的管理]
Z Gerontol Geriatr. 2018 Jan;51(1):113-125. doi: 10.1007/s00391-017-1355-7. Epub 2018 Jan 5.
9
Denosumab or Zoledronic Acid in Postmenopausal Women With Osteoporosis Previously Treated With Oral Bisphosphonates.地诺单抗或唑来膦酸用于曾接受口服双膦酸盐治疗的绝经后骨质疏松症女性。
J Clin Endocrinol Metab. 2016 Aug;101(8):3163-70. doi: 10.1210/jc.2016-1801. Epub 2016 Jun 6.
10
Comparison of Teriparatide and Denosumab in Patients Switching From Long-Term Bisphosphonate Use.比较特立帕肽和地舒单抗在长期使用双膦酸盐类药物的患者中的应用。
J Clin Endocrinol Metab. 2019 Nov 1;104(11):5611-5620. doi: 10.1210/jc.2019-00924.
引用本文的文献
1
Osteoporosis in Patients With Respiratory Diseases.呼吸系统疾病患者的骨质疏松症
Front Physiol. 2022 Jul 12;13:939253. doi: 10.3389/fphys.2022.939253. eCollection 2022.
本文引用的文献
1
The COVID-19 Pandemic in the US: A Clinical Update.美国的新冠疫情：临床最新情况
JAMA. 2020 May 12;323(18):1767-1768. doi: 10.1001/jama.2020.5788.
2
Covid-19 and Health Care's Digital Revolution.新冠疫情与医疗保健的数字革命
N Engl J Med. 2020 Jun 4;382(23):e82. doi: 10.1056/NEJMp2005835. Epub 2020 Apr 2.
3
Pharmacological Management of Osteoporosis in Postmenopausal Women: An Endocrine Society* Clinical Practice Guideline.绝经后妇女骨质疏松症的药物治疗：内分泌学会临床实践指南*。
J Clin Endocrinol Metab. 2019 May 1;104(5):1595-1622. doi: 10.1210/jc.2019-00221.
Zotero 插件